← Rocket Lab USA overview

Rocket Lab USA vs Lockheed Martin: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Rocket Lab USA Inc. (RKLB)

Q3 2026
▲2▼2

Neutron Delay and Margin Miss Weigh on Rocket Lab

  • Record Q2 Revenue and Backlog Q2 revenue hit a record $234M, up 62% from a year ago, with a $2.36B backlog. Big Space Force wins (~$700M) and a $266M suborbital contract boosted future work.

    Shows strong demand and financial growth, a key positive for the stock.

  • Iridium Acquisition Clears Antitrust The $8B Iridium deal cleared antitrust review and adds 2.55M subscribers, expanding Rocket Lab's space services. But it also brought heavy dilution: 29.3M shares and $1.94B raised.

    Major strategic move that transforms the company, with both benefits and costs.

  • Neutron First Launch Delayed Neutron's first launch slipped to late 2026 or 2027 after a tank failure. A full-duration engine test passed, but the delay pushes back a key growth driver.

    Neutron is central to Rocket Lab's future, so delay is a major negative.

  • Margin Miss and Governance Risks Q3 gross margin guidance of 29–31% badly missed, sending shares down 9%. Adjusted EBITDA losses persist, and CEO Peter Beck's 5M-share sale, a securities class action, and Iridium deal-fairness probes add risk.

    Directly hit investor confidence and stock price, with ongoing overhangs.

August 2026
▲2▼2

Rocket Lab's record revenue and contracts offset by Neutron delay and margin miss

  • Record Q2 revenue and backlog Rocket Lab reported record Q2 revenue of $234 million, up 62% year over year, and a backlog of $2.36 billion, showing strong demand for its launch and space systems services.

    This is a key new financial milestone that demonstrates the company's growth trajectory.

  • Major Space Force wins and Iridium deal clears antitrust Rocket Lab won about $700 million in Space Force contracts and a record $266 million suborbital contract, while its $8 billion acquisition of Iridium cleared antitrust review, adding recurring revenue and scale.

    These are significant new contract awards and a regulatory milestone that expand the business.

  • Neutron first launch delayed after tank failure Neutron's first launch has slipped to late 2026 or possibly 2027 after a tank failure, delaying a key growth catalyst and raising execution concerns.

    This is a new setback that affects the timeline for a major future revenue driver.

  • Q3 gross margin guidance misses, shares fall 9% Q3 gross margin guidance of 29–31% badly missed expectations, causing shares to fall 9%, while adjusted EBITDA losses continue and the Iridium deal requires heavy debt and stock financing, keeping the stock volatile.

    This is a new negative development that directly impacted investor sentiment and the stock price.

Latest
▲4

Rocket Lab's Iridium Deal, Defense Wins, and Synspective Demand Drive Upside

  • Iridium acquisition adds recurring revenue and scale Rocket Lab agreed to buy Iridium for $8 billion, gaining 2.55 million subscribers and steady cash flow. The stock jumped 24% on the news. This makes Rocket Lab a broader space company, not just a launch provider, which supports a higher value.

    The Iridium deal is the biggest new event this period and directly changes Rocket Lab's business and stock story.

  • Record-fast Space Force mission proves rapid launch capability Rocket Lab completed the VICTUS HAZE mission for the Space Force in record time, launching just 16 hours after notice. This shows its ability to respond quickly for defense customers, which can lead to more government contracts and revenue.

    This new mission success demonstrates a unique capability that could drive future defense demand.

  • SpaceX IPO sell-off creates buying opportunity A sell-off in space stocks after the SpaceX IPO made Rocket Lab shares cheaper despite strong revenue growth and a large backlog. Analysts see this as a sentiment-driven dip, not a fundamental problem, which could attract buyers and lift the stock.

    This explains a recent price drop and why it may reverse, directly addressing the stock's movement.

  • Synspective launches and new 20-mission contract boost demand Rocket Lab completed two Electron launches for Synspective and signed a multiyear deal for 20 more, its largest commercial Electron contract. This adds to its launch backlog and shows growing demand for its small rockets, supporting future revenue.

    This new contract and successful launches directly increase Rocket Lab's backlog and demonstrate commercial demand.

September 2026
▲2▼1

Rocket Lab expands defense, funds Iridium, but dilution and Neutron risks weigh

  • Defense contract wins and backlog growth Rocket Lab won a Space Force prime spot, a Viasat satellite award, and $456 million in new hypersonic and suborbital contracts, lifting backlog 137% to $2.36 billion. This shows strong demand for its defense and space services.

    These new contracts are a key positive driver for the stock, indicating growing demand and future revenue.

  • Iridium acquisition fully funded Rocket Lab fully funded its $8 billion Iridium acquisition, adding 2.55 million subscribers and roughly doubling revenue. This transforms the company's scale and recurring revenue base.

    Completing the funding for this major acquisition is a significant positive event that reshapes the company's financial profile.

  • Heavy share dilution from Iridium deal The Iridium deal required heavy share dilution (29.3 million shares plus $1.94 billion raised), shrinking investor ownership. This dilutes existing shareholders and can pressure the stock price.

    Dilution is a direct negative for current shareholders and a key counterweight to the acquisition's benefits.

  • Neutron launch window narrows, SpaceX rideshare halt helps Neutron's end-of-2026 launch window is narrowing, but SpaceX's Falcon 9 rideshare halt benefits Neutron. Analysts initiated coverage with $80–$122 targets, reflecting mixed sentiment.

    This captures both the ongoing risk of Neutron delays and the competitive opportunity from SpaceX's move, plus analyst attention.

▲4

Rocket Lab Advances Iridium Deal, Wins Defense Work, Neutron Nears

  • Iridium acquisition fully financed and heads to shareholder vote Rocket Lab raised $1.94 billion via share sales to fund its $8 billion Iridium purchase, replacing a $3.6 billion bridge loan and cutting debt needs. Iridium shareholders vote on September 24. The deal adds Iridium's satellite network and 2.55 million subscribers, roughly doubling revenue, but the extra shares dilute existing investors.

    This is the biggest event of the period, directly affecting Rocket Lab's capital structure and future revenue.

  • New defense contracts add $456 million to backlog Rocket Lab won a $190 million award for 20 HASTE hypersonic test flights and a $266 million Space Force contract for at least 12 suborbital missions. These add to its backlog and show growing government demand for its launch services, supporting future revenue and the stock.

    These new contracts are concrete evidence of expanding defense demand, a key growth driver.

  • SpaceX halts Falcon 9 rideshare, opening door for Neutron SpaceX stopped taking new Falcon 9 rideshare reservations, betting Starship will fill the gap. Rocket Lab's Neutron rocket targets the same medium-lift market. With backlog up 137% to $2.36 billion and 90+ launches under contract, Rocket Lab is the most direct beneficiary, though Neutron's end-of-2026 launch window is narrowing.

    This is a major competitive shift that could hand Rocket Lab a larger share of the launch market.

  • Analyst coverage starts with high price targets Raymond James initiated coverage with an $80 target and Cantor Fitzgerald reiterated a $122 target, both citing Neutron's first launch and the Iridium deal as catalysts. These ratings can boost investor confidence and attract new buyers, pushing the stock up.

    Analyst ratings influence investor sentiment and can drive short-term price moves.

▲2

Rocket Lab Wins Defense Work, Funds Iridium, But Neutron Slips

  • Defense demand expands with new Space Force and Viasat awards Rocket Lab won a prime spot on a nearly $1 billion Space Force program and was picked by Viasat to build a secure military satellite. These add to its backlog and show government demand for its launch and satellite work, supporting future revenue and the stock.

    New defense contracts directly increase Rocket Lab's future revenue pipeline.

  • New solar cell and component sales widen its product lineup Rocket Lab released a lighter, germanium-free solar cell and is selling avionics, radios and batteries used on over 1,800 missions. These products open new markets beyond launch, adding revenue streams that can grow with satellite demand and support the stock.

    New products expand Rocket Lab's addressable market and revenue sources.

  • Iridium acquisition fully funded, but with heavy share dilution Rocket Lab fully financed its $8 billion Iridium purchase by issuing 29.3 million shares, removing deal uncertainty but diluting existing shareholders. The deal adds Iridium's revenue and cash flow, yet the extra shares mean each investor owns a smaller slice, weighing on the stock.

    Financing removes a major risk but the dilution is a real counterweight for shareholders.

▲3▼1

Rocket Lab's Contract Wins and Iridium Progress Offset Neutron Delay

  • Record $266M Space Force suborbital launch contract Rocket Lab won its largest launch contract ever: about $266 million from the U.S. Space Force for roughly a dozen suborbital launches, with the first expected by end-2026. This adds to its backlog and proves government demand for its HASTE program, supporting future revenue and the stock.

    This is a new, large contract win that directly boosts Rocket Lab's backlog and revenue outlook.

  • Iridium acquisition clears US antitrust review and financing arranged The Hart-Scott-Rodino waiting period expired, clearing US antitrust review for the $8 billion Iridium deal. Rocket Lab has a $3.6 billion bridge loan and can sell up to $1.94 billion of stock. This reduces deal uncertainty and moves the strategic expansion forward, supporting the stock.

    This is a new regulatory milestone that de-risks the Iridium acquisition, a major strategic move.

  • Space Force consortium wins and $12M orders for secure satellite network Rocket Lab joined the Space Force's Space Data Network Consortium and won two $12 million orders to demonstrate secure optical communications. This positions it in a key military satellite network program, potentially leading to more defense work and revenue, supporting the stock.

    This is a new contract win and consortium membership that expands Rocket Lab's defense business.

  • Neutron first launch may slip to 2027 Rocket Lab's Neutron rocket timeline softened, with an analyst noting the first launch could be pushed to 2027. Neutron is key to competing for larger launch contracts, so further delay keeps a major growth catalyst on hold and pressures the stock.

    This is a new update on the Neutron timeline that affects a critical future growth driver.

▲3▼1

Record Revenue and Backlog, but Margin Miss and Iridium Deal Weigh

  • Record Q2 revenue and backlog Rocket Lab reported record second-quarter revenue of $234 million, up 62% from a year ago, and a record backlog of $2.36 billion, up 137%. It guided next quarter to another record. This shows the business is growing fast and winning more work, which supports the stock.

    This is the core new financial result that shows the company's growth and supports the stock.

  • Weak margin guidance and continued losses Despite record revenue, Rocket Lab guided third-quarter gross margin to 29%-31%, far below the roughly 37.6% analysts expected, and still expects an adjusted EBITDA loss of $17-$23 million. Investors focused on this, sending shares down 9% on August 11. Lower profitability than hoped pressures the stock.

    This is the main counterweight that explains why the stock fell despite record revenue.

  • Iridium acquisition agreement Rocket Lab agreed to acquire Iridium Communications for about $54 per share, aiming to combine Iridium's satellite network with its launch and manufacturing. The deal would expand Rocket Lab beyond launch into satellite services, a strategic growth move, though it still needs approvals and is expected to close mid-2027.

    This is a major new strategic move that could reshape the company and drive long-term value.

  • New launch contracts and acquisitions Rocket Lab signed over $437 million in new launch contracts in Q2 and after, pushing its launch backlog past 90 missions. It also closed the acquisitions of Mynaric and Motiv and introduced its GHOST launch system. These expand its offerings and future revenue, supporting the stock.

    These new contracts and acquisitions show growing demand and expanded capabilities, supporting future revenue.

▲3▼1

Rocket Lab Wins Big Space Force Deals, But Neutron Delay and Iridium Financing Weigh

  • Two major Space Force contract wins add nearly $700M to backlog Rocket Lab won a $397 million Space Force contract to build, launch and operate Flatellite satellites, plus a $266 million award for 12 suborbital launches. These add to its $2.2 billion backlog and show government demand for its full range of services, supporting future revenue and the stock.

    These are the largest new contract wins this period and directly boost future revenue and backlog.

  • Rapid-response mission proves Rocket Lab can do more than launch Rocket Lab completed the Victus Haze mission for the Space Force, supplying the rocket, spacecraft and on-orbit operations in one contract. This shows it can earn more revenue per customer and win repeat orders, though the contract is small versus its backlog.

    It demonstrates a new integrated capability that could lift future revenue per mission.

  • SpaceX launch capacity crunch leaves room for Rocket Lab SpaceX is using most Falcon 9 launches for its own Starlink network, with commercial capacity sold out until 2028 or 2029. This pushes satellite operators toward alternatives like Rocket Lab's upcoming Neutron rocket, strengthening its competitive position and long-term demand.

    It explains a key external force that could drive customers to Rocket Lab.

  • Neutron delay and Iridium financing still weigh on the stock Neutron's first launch slipped to later 2026 after a tank failure, and the $8 billion Iridium acquisition needs heavy debt and stock financing. Until Neutron flies and the deal closes, these overhangs keep the stock volatile and below analyst targets, even as contracts roll in.

    It is the main counterweight to the positive contract news and explains why the stock remains depressed.

July 2026
▲2▼1

Rocket Lab advances on Neutron, contracts, but insider sale and legal risks weigh

  • Neutron rocket progress Rocket Lab's Neutron rocket passed a full-duration engine test and revealed a reusable fairing, key milestones for its next-generation vehicle. Analysts also highlighted Rocket Lab as a top SpaceX alternative with a $2.2B backlog.

    Neutron progress and analyst endorsement are positive operational and sentiment drivers.

  • New government contracts Rocket Lab won a spot in the $5.6B Space Force NSSL Phase 3 Lane 1 program and a $266M Air Force suborbital contract, expanding its government business. It also completed two NASA Mars Escapade spacecraft and expanded launch infrastructure.

    Contract wins and NASA milestones are new positive business developments.

  • CEO share sale and legal issues CEO Peter Beck sold 5 million shares, dropping the stock 10.4%. A securities class action over Neutron timeline disclosures and a $3B equity offering threaten dilution, while a law firm probes the Iridium deal's fairness.

    Insider selling and legal/dilution risks are major negative pressures on the stock.

  • Iridium acquisition update Iridium, Rocket Lab's acquisition target, posted 4% revenue growth, but shares fell nearly 20% after the deal announcement and a law firm is investigating the deal's fairness.

    Iridium's growth is positive, but the stock drop and investigation create mixed signals.

▲4

Rocket Lab Wins $456M in New Contracts, Advances NASA Mars Mission

  • Rocket Lab wins $266M U.S. Air Force contract for 12 suborbital launches The U.S. Air Force awarded Rocket Lab a $266 million contract for 12 suborbital launches by 2028. This adds to the backlog and shows growing demand for its HASTE program, supporting future revenue and lifting the stock.

    This is a new, material contract win that directly boosts Rocket Lab's backlog and revenue outlook.

  • Rocket Lab completes two spacecraft for NASA Mars mission Rocket Lab finished two spacecraft for NASA's Escapade mission to Mars, set for October launch. This proves its spacecraft-building capability, which could lead to more NASA and commercial contracts, supporting the stock.

    This milestone demonstrates execution on a high-profile NASA mission, potentially unlocking future contracts.

  • Rocket Lab expands launch infrastructure for more frequent missions Rocket Lab is adding ground systems, mission control, and launch sites to handle more launches for commercial and national security customers. This capacity expansion positions it to capture growing demand and scale revenue.

    Infrastructure investment signals confidence in future demand and supports higher launch cadence.

  • Iridium reports revenue growth and completes Aireon acquisition Iridium, which Rocket Lab is acquiring, reported 4% revenue growth and completed its Aireon purchase, adding $100M in annual service revenue. This strengthens the strategic case for the deal, though it still awaits approval.

    Positive developments at Iridium support the rationale for Rocket Lab's pending acquisition, reducing uncertainty.

▲3▼1

Neutron Progress and Space Force Win Boost Rocket Lab, but Iridium Deal Fallout Weighs

  • Neutron engine test and new fairing design Rocket Lab completed a full-duration second-stage engine test for its Neutron rocket and revealed a reusable 'Hungry Hippo' fairing. These advances support the case for a working medium-lift rocket, which could unlock bigger defense and constellation launches, lifting the stock.

    This is a new technology milestone that directly addresses the key uncertainty around Neutron's timeline.

  • Selected for $5.6B Space Force launch program Rocket Lab won a spot in the Space Force's National Security Space Launch Phase 3 Lane 1 program, worth up to $5.6 billion. It can't win task orders until Neutron flies, but the selection opens a huge government market and supports future revenue.

    This is a new contract win that expands Rocket Lab's addressable defense market.

  • Iridium deal fairness investigation and stock decline A law firm is investigating whether Iridium's board acted fairly in selling to Rocket Lab. Since the deal was announced, Rocket Lab shares have fallen nearly 20%, and the probe adds uncertainty about the acquisition's terms and integration, pressuring the stock.

    This is a new legal development that adds a real counterweight to the bullish news.

  • Record first-half performance and analyst optimism Rocket Lab stock rose 46% in the first half on record revenue, 106% backlog growth, and more launches sold in Q1 than all of last year. Analysts remain bullish with an average target of $117, though the stock has pulled back recently.

    This summarizes the strong fundamental momentum that continues to attract investors.

▼2▲1

Rocket Lab's Iridium Deal and Neutron Hopes Face Insider Selling and Legal Risks

  • Rocket Lab seen as top SpaceX alternative with $2.2B backlog Analysts and media highlight Rocket Lab as a more reasonably valued way to invest in space, noting its record launch contract and backlog over $2.2 billion. This draws investor attention and money away from SpaceX, supporting demand for RKLB shares.

    This explains why investors are choosing Rocket Lab over SpaceX, a key force behind the stock's appeal.

  • CEO sells 5 million shares, stock drops 10.4% CEO Peter Beck sold 5 million shares under a pre-arranged plan, causing a sharp 10.4% drop. While the sale was planned, it spooked investors and added selling pressure, especially after the stock had run up on the Iridium news.

    This is a major negative event that directly hit the stock price and investor sentiment this period.

  • Legal and financing overhangs: class action and $3B equity offering A securities class action filed July 1 over Neutron timeline disclosures and a $3 billion at-the-market equity offering announced June 24 create near-term risks. These can dilute shares and weigh on the stock until resolved.

    These are new negative factors that could pressure the stock and are not yet fully priced in.

Q2 2026
▲3▼1

Rocket Lab rides Nasdaq-100 inclusion, Iridium deal, and record launch cadence

  • Nasdaq-100 inclusion Joining the Nasdaq-100 index on June 22 forced index-tracking funds to buy RKLB shares, creating steady demand and lifting the stock.

    Index inclusion is a major new demand catalyst for the stock.

  • Iridium acquisition transforms company Rocket Lab agreed to buy Iridium for $8 billion at a 24% premium, turning it into a full-service space company and sending shares up about 16%.

    The transformative acquisition is the biggest new strategic event of the period.

  • Record launch cadence and repeat demand NASA booked three Electron launches, a tenth straight Synspective launch was confirmed with 17 more booked, and a record 16h42m Space Force turnaround showed operational strength.

    These operational wins demonstrate growing demand and execution capability.

  • SpaceX IPO and Starfall test pressure SpaceX's IPO siphoned investor attention and capital from small space stocks, while its successful Starfall reentry pod test beat Rocket Lab's in-development system.

    This is the main competitive and capital headwind facing Rocket Lab.

June 2026
▲3▼1

Rocket Lab rides Nasdaq-100 inclusion, Iridium deal, and record launch cadence

  • Nasdaq-100 inclusion Joining the Nasdaq-100 index on June 22 forced index-tracking funds to buy RKLB shares, creating steady demand and lifting the stock.

    Index inclusion is a major new demand catalyst for the stock.

  • Iridium acquisition transforms company Rocket Lab agreed to buy Iridium for $8 billion at a 24% premium, turning it into a full-service space company and sending shares up about 16%.

    The transformative acquisition is the biggest new strategic event of the period.

  • Record launch cadence and repeat demand NASA booked three Electron launches, a tenth straight Synspective launch was confirmed with 17 more booked, and a record 16h42m Space Force turnaround showed operational strength.

    These operational wins demonstrate growing demand and execution capability.

  • SpaceX IPO and Starfall test pressure SpaceX's IPO siphoned investor attention and capital from small space stocks, while its successful Starfall reentry pod test beat Rocket Lab's in-development system.

    This is the main competitive and capital headwind facing Rocket Lab.

▲2▼1

Rocket Lab's $8B Iridium Deal Reshapes Space Sector

  • Rocket Lab to acquire Iridium for $8 billion Rocket Lab agreed to buy Iridium Communications for $54 per share in cash and stock, a 24% premium. This transforms Rocket Lab from a launch provider into a full-service space company with its own satellite network and customers. The stock jumped about 16% on the news.

    This is the single biggest new event of the period and directly explains the stock's sharp move.

  • Space sector rally lifts peers after deal The Iridium deal sparked a broad rally in space stocks, with Planet Labs and Viasat surging on speculation of more consolidation. This shows investors see space assets as valuable strategic infrastructure, which can lift Rocket Lab's whole sector and its own valuation.

    It shows the deal's ripple effect and renewed investor interest in the space sector, which supports RKLB's price.

  • SpaceX's Starfall reentry pod tests successfully SpaceX successfully tested a reentry cargo pod, giving it a lead over Rocket Lab, whose own reentry system is still in development. This is a competitive threat in the emerging market for returning cargo from space, which could limit Rocket Lab's future growth in that area.

    It is a new competitive development that could weigh on Rocket Lab's long-term prospects.

  • Iridium valuation debate adds integration risk Analysts note Iridium may be undervalued on cash flow but expensive on earnings, and the pending acquisition adds complexity. While the deal is expected to close in mid-2027, integration risks and the premium paid could pressure Rocket Lab if the combined company doesn't deliver expected benefits.

    It provides a fair counterweight, highlighting that the deal is not without risks and could affect RKLB's stock if integration stumbles.

▲3

Rocket Lab wins NASA and defense deals, but SpaceX IPO still weighs on shares

  • NASA books three Electron launches NASA picked Rocket Lab for three dedicated Electron launches for the PolSIR and TSIS-2 science missions starting early 2027. New government contracts add to the backlog and show customers keep choosing Electron, supporting future revenue and the stock.

    A fresh contract win that adds demand and backlog, directly supporting the bull case.

  • Record 17-hour Space Force launch turnaround Rocket Lab launched the Space Force VICTUS HAZE mission just 16 hours 42 minutes after notice, beating the old record by over 10 hours. It proves the company can respond fast to military needs, strengthening its case for more defense work.

    A new operational milestone that boosts Rocket Lab's credibility for national security contracts.

  • Tenth straight Synspective launch, 17 more booked Rocket Lab placed another satellite for Japan's Synspective, its tenth dedicated launch for them with 100% success. Seventeen more missions are already booked, showing repeat customers and steady launch demand that supports revenue growth.

    New evidence of recurring customer demand and launch reliability, key to the growth story.

▲3▼1

Rocket Lab joins Nasdaq-100, buys Motiv, but SpaceX IPO pulls small space stocks down

  • Nasdaq-100 inclusion Rocket Lab will join the Nasdaq-100 index on June 22, which typically forces index-tracking funds to buy the stock. This new demand can push the share price up, and it also raises the company's profile among big investors.

    This is a major new event that directly increases demand for RKLB shares.

  • Motiv Space Systems acquisition Rocket Lab acquired Motiv Space Systems, adding robotic arms and precision parts used on NASA's Perseverance rover. This expands its space systems business, making the company less dependent on launches and more valuable as a full-service space company.

    This new acquisition strengthens Rocket Lab's technology and revenue mix, supporting a higher valuation.

  • SpaceX IPO shifts investor attention SpaceX's huge IPO has pulled investor money and attention away from smaller space stocks. Rocket Lab fell about 5% as investors chose SpaceX instead, and this competition for investor dollars could keep pressuring the stock.

    This is a new competitive force that directly hurt RKLB's stock price and sentiment.

  • Strong Q1 revenue growth and analyst targets Rocket Lab reported 63.5% revenue growth, beating estimates, and analysts raised price targets to $129 and even a bull case of $150. Strong financial results and optimistic forecasts can attract buyers and lift the stock.

    This new earnings beat and analyst upgrades provide fundamental support for the stock price.

Lockheed Martin Corporation (LMT)

Q3 2026
▲3▼1

Lockheed rides record orders and war demand, but setbacks bite

  • Record $230B backlog and raised guidance Lockheed's order backlog hit a record $230B, giving visibility for years, and management raised guidance, signaling confidence in future sales and profits.

    This shows the core demand strength that drove the quarter.

  • Massive Patriot and Saudi F-35 orders A $58.6B Patriot order and a $24.3B Saudi F-35 sale were among the largest awards, boosting long-term revenue and reinforcing Lockheed's global market position.

    These are new, concrete contract wins that underpin growth.

  • Missile sales surge on Iran war Missile sales jumped about 20% amid the Iran war, and Lockheed tripled PAC-3 output, meeting urgent demand and driving near-term revenue higher.

    This highlights the direct impact of geopolitical conflict on sales.

  • F/A-XX loss and F-35 cost overruns Lockheed lost the $20B Navy F/A-XX contract to Boeing and F-35 costs rose $51B to $536B amid Block 4 delays, raising concerns about future competitiveness and profitability.

    These are major setbacks that could weigh on growth and margins.

August 2026
▲3▼1

Lockheed rides missile demand surge but loses $20B Navy fighter contract

  • Pentagon prioritizes missile defense, record Patriot order The Pentagon named Patriot, THAAD, and NGI as priorities, and the Army placed a record $58.6B Patriot order—about nine times current production—while $3B more funds tripling PAC-3 output.

    This is the core new demand driver that lifted Lockheed's outlook during the period.

  • New contract wins and successful tests Lockheed won Strigo modular missile work, a successful NGI motor test, drone and uncrewed-vessel demonstrations, and $1B in Navy and Japan awards, adding fresh revenue opportunities.

    These new wins and milestones show Lockheed is converting demand into concrete orders and technical progress.

  • Cramer highlights $230.4B backlog Jim Cramer pointed to Lockheed's $230.4B backlog, reinforcing investor confidence in the company's long-term revenue visibility and strong order book.

    This public endorsement drew attention to Lockheed's massive backlog, supporting positive sentiment.

  • Loses $20B Navy F/A-XX fighter contract to Boeing Lockheed lost the $20B Navy F/A-XX fighter contract to Boeing, eliminating a major long-term revenue stream and leaving Boeing with both next-generation fighter programs.

    This is the key negative event that removed a significant future revenue source and shifted competitive balance.

Latest
▲3▼1

Lockheed's missile output accelerates, but F/A-XX loss stings

  • PAC-3 MSE parts arrive in 22 days, output ramp on track Lockheed received its first GM Defense-made PAC-3 MSE interceptor housings just 22 days after the manufacturing deal, a key step toward tripling annual output to 2,000. Faster production supports the Army's seven-year, $58.6B framework and future revenue.

    Shows concrete progress on the missile expansion that is Lockheed's biggest growth driver.

  • New Navy and Japan awards add $1B to backlog Lockheed won a $245M Navy modification for F/A-18 IRST Block II systems, a $52M F-35 engineering change, and a $724M Japan Aegis combat-system contract. These firm orders add to the backlog and support revenue for years.

    Concrete new contract wins that directly add to Lockheed's order book.

  • Navy doubles MQ-25 control stations using Lockheed software The Navy stood up a second MD-5C ground control station powered by Lockheed's MDCX software, doubling carriers able to operate the MQ-25A Stingray. This expands Lockheed's role in unmanned carrier aviation and could lead to more software and support revenue.

    New program milestone that broadens Lockheed's franchise beyond missiles and F-35.

  • Lockheed eliminated from $20B Navy F/A-XX fighter Boeing won the Navy's next-generation F/A-XX carrier fighter contract worth over $20B; Lockheed was eliminated in 2025. Losing this future franchise removes a long-term revenue opportunity and leaves Boeing with both major next-gen fighter programs.

    A real competitive loss that removes a future revenue stream and shifts the fighter landscape.

September 2026
▲3▼1

Lockheed wins $24B Saudi F-35 deal, missile demand surges

  • Saudi F-35 sale and F-35 expansion Lockheed won a $24.3B sale of F-35 fighter jets to Saudi Arabia, a major new order that expands the F-35 program internationally and adds significant long-term revenue.

    This is a new, large contract win that directly boosts Lockheed's revenue outlook.

  • Missile demand and new frameworks The Pentagon locked in a seven-year missile framework, Sweden ordered $729M in HIMARS, and Javelin co-production opened India's market. Lockheed also won a JATM framework with $2B added and $2.5B in PrSM and Pentagon awards.

    These new orders and frameworks show strong and growing demand for Lockheed's missile products.

  • Production ramp and analyst upgrade PAC-3 output is tripling, Germany's first F-35A rolled out, and UBS upgraded Lockheed stock, reflecting confidence in the company's production ramp and future earnings.

    These developments signal operational progress and positive analyst sentiment, supporting the stock.

  • F-35 cost overruns and geopolitical cooling F-35 acquisition costs rose $51B to $536B amid Block 4 delays, pressuring budgets and future orders. Defense stocks also slid 3% after Iran offered to reopen the Strait of Hormuz, cooling the geopolitical risk premium.

    These are new negative factors that could weigh on Lockheed's stock price.

▲3▼1

Lockheed's missile and F-35 order book swells, but peace talk cools defense trade

  • Lockheed wins $1.2B PrSM and $1.3B Pentagon contract haul Lockheed won a $1.2 billion Army contract for PrSM Increment 2 missiles and three other Pentagon awards worth over $1.3 billion, including a major missile deal. These add to the order backlog and support future revenue, pushing the stock up.

    New contract wins directly add to Lockheed's backlog and revenue outlook.

  • AIM-260 missile unveiled with Pentagon production framework Lockheed unveiled the AIM-260 Joint Advanced Tactical Missile and signed a Pentagon framework to speed production and prepare for a multiyear buy. It could replace the AMRAAM as the top US air-to-air missile, opening a large new franchise.

    New missile program and production agreement signal future revenue growth.

  • Saudi F-35 sale advances; Germany's first F-35A rolls out The US notified Congress of a plan to sell up to 48 F-35s to Saudi Arabia, a first for the kingdom, while Germany's first F-35A was presented. Both expand the F-35 customer base and long-term revenue pipeline.

    New F-35 orders and deliveries expand Lockheed's flagship franchise.

  • Defense stocks slide as Iran offers to reopen Strait of Hormuz Lockheed fell 3% after Iran offered to reopen the Strait of Hormuz, reducing the geopolitical risk premium that had boosted munitions demand expectations. The move extends a month-long de-rating, showing how quickly peace signals can cool defense stocks.

    Geopolitical de-escalation directly pressures defense stock valuations.

▲4

Lockheed wins $24B Saudi F-35 order, JATM boost, UBS upgrade

  • Saudi Arabia approves $24.3B F-35 sale The State Department cleared a potential $24.3 billion sale of 48 F-35s to Saudi Arabia, pending Congress. This is a huge new order for Lockheed's flagship jet, adding billions in future revenue and showing the F-35 franchise keeps growing beyond current customers.

    This is the largest new demand event in the period and directly boosts Lockheed's future revenue.

  • Pentagon framework for JATM missile with $2B budget boost Lockheed struck a multi-year production framework for the Joint Advanced Tactical Missile, with a $2 billion budget increase proposed. JATM would replace RTX's AMRAAM as the top US air-to-air missile, opening a large new franchise and reinforcing Lockheed's missile leadership.

    New missile program win expands Lockheed's addressable market and future revenue.

  • UBS upgrades LMT to Buy, sees earnings above consensus UBS upgraded Lockheed to Buy, projecting revenue and earnings well above Wall Street estimates through 2028, driven by missile production and growth beyond the F-35. Analyst support can draw more investors and lift the stock as confidence in Lockheed's growth story builds.

    Analyst upgrade directly influences investor sentiment and capital flows into the stock.

  • PAC-3 production ramp with GM Defense parts, plus Black Hawk order Lockheed delivered the first PAC-3 MSE components from GM Defense in just 22 days and plans to triple PAC-3 output to 2,000, backed by $8-9B investment. Separately, Sikorsky won a $234M Army contract for 16 Black Hawks, adding steady revenue.

    Shows concrete progress in scaling missile production and steady helicopter demand, supporting revenue growth.

▲3▼1

Lockheed's missile demand surges as F-35 costs rise and new tech bets expand

  • DoD locks in 7-year missile expansion with Lockheed as prime The Pentagon signed seven-year framework agreements with General Dynamics and Lockheed to triple PAC-3 MSE and quadruple THAAD production, with guaranteed minimum annual purchases. Lockheed is prime contractor on both interceptors, giving long-term revenue visibility and supporting the stock, though final values depend on congressional funding.

    This is the period's biggest demand signal, directly locking in multi-year missile revenue for Lockheed.

  • Sweden orders $729M HIMARS, adding European customer Sweden committed about $729 million for roughly ten HIMARS launchers plus ammunition, with deliveries from 2027 and co-production with Saab in Sweden. This adds another European customer to Lockheed's fast-growing precision-fire franchise, feeding a 19% surge in missile sales and supporting future revenue.

    A concrete new international order that shows HIMARS demand broadening beyond the U.S.

  • Javelin co-production deal opens India market Lockheed's Javelin joint venture with RTX signed an MOU with Tata Advanced Systems to explore co-producing Javelin All Up Rounds in India, with final assembly and component production planned there. This expands the Javelin supply chain, improves Indo-Pacific resilience, and could open doors to future orders and technology collaboration.

    A new geographic expansion of a key missile franchise that could add orders and supply-chain capacity.

  • F-35 acquisition cost rises $51B to $536B The projected cost to acquire the Pentagon's F-35 fleet rose by about $51 billion to roughly $536 billion, a 10% increase, driven by more expensive F-35C variants and delayed Block 4 modernization. This raises budget pressure on the program and could slow future orders or funding, a headwind for Lockheed.

    The main counterweight this period: rising costs on Lockheed's largest program could squeeze future budgets and orders.

▲3

Lockheed's missile demand stays hot as new tech bets expand

  • New Strigo modular missile line targets faster sales Lockheed launched Strigo, a modular family of missile sensors, datalinks and seekers, with $250 million committed and a dedicated product center. It aims to move from design to tested capability in months, which could win new contracts and speed up deliveries, supporting future revenue and the stock.

    It is a new product launch that expands Lockheed's addressable market and shows innovation, a fresh positive driver.

  • Next Generation Interceptor motor test passes Lockheed's NGI Stage 2 rocket motor passed a key static-fire test simulating space conditions, confirming performance for fielding by 2030. This de-risks a major missile-defense program and strengthens Lockheed's position in the growing homeland defense market, a positive for long-term earnings.

    It is a new milestone on a key program that reduces execution risk and supports future revenue.

  • Drone and uncrewed vessel tests open new markets Lockheed demonstrated an AI drone-detection system using 5G networks and, with Saildrone, fired missiles from an uncrewed boat during a Navy exercise. These tests show new ways to sell weapons and sensors, potentially adding future orders beyond traditional missiles, though no contracts are signed yet.

    It highlights new technology demonstrations that could lead to future contracts, a fresh growth angle.

▲4

Pentagon's urgent missile buildup hands Lockheed a record $58.6B Patriot order

  • Pentagon orders faster weapons output, Lockheed named priority The Pentagon told Boeing, Lockheed and RTX to speed up weapons production, giving them 21 days to propose faster deliveries. Lockheed's Patriot, THAAD and Next Generation Interceptor programs are named priorities. This points to more orders and higher output, pushing the stock up.

    This is the new demand signal from the government that drives Lockheed's future revenue.

  • Army places $53.9B Patriot order, total deal $58.6B The U.S. Army ordered $53.9 billion of Patriot PAC-3 missiles from Lockheed, part of a seven-year deal worth up to $58.6 billion. The order aims to replace missiles used in the Iran war and build stockpiles, implying production about nine times current levels. This locks in huge long-term revenue.

    This is the concrete, massive contract that directly boosts Lockheed's backlog and future sales.

  • Pentagon adds $3B for Patriot and THAAD parts The Pentagon signed a $3 billion deal with Lockheed and Northrop to expand production of Patriot and THAAD interceptor parts, including a $2 billion framework to triple PAC-3 MSE output and $1 billion for THAAD components. This helps Lockheed make more missiles faster, supporting revenue growth.

    It shows the supply chain is being scaled up to meet the new demand, reducing a key bottleneck.

  • Cramer calls Lockheed a sensational buy after record backlog Jim Cramer praised Lockheed on CNBC, pointing to its record $230.4 billion backlog, 11% sales growth, and raised profit guidance. While this is just one commentator's opinion, it can draw investor attention and support the stock price in the short term.

    It reflects the positive sentiment around Lockheed's strong results, though it is not a fundamental driver.

July 2026
▲3▼1

Lockheed's record backlog and Q2 beat offset by execution and supply risks

  • Record $230B backlog and Q2 beat with raised guidance Lockheed reported a record $230B order backlog and beat Q2 earnings estimates, then raised its full-year guidance. This shows strong demand and better-than-expected execution, giving investors confidence in future growth.

    This is the core positive event of the period, showing accelerating demand and improved financial performance.

  • Major contract wins: Patriot, Golden Dome, Special Ops, NATO Lockheed won a Patriot contract worth up to $58.6B, a $1.1B Golden Dome satellite award, a $10.5B Special Ops logistics deal, and $57B in NATO procurement. These wins lock in long-term revenue and reinforce its market dominance.

    These large awards are new and directly support future revenue growth, a key driver for the stock.

  • Iran war lifts missile sales ~20%; supply-chain deals ease rare-earth risks The Iran war boosted missile sales by about 20%, and new supply-chain agreements helped reduce rare-earth material risks. This shows how geopolitical tensions can drive demand and how Lockheed is addressing input shortages.

    This explains a key demand driver and a mitigation effort for a major supply risk, both new this period.

  • Q1 miss, negative free cash flow, Dark Eagle delays, rare-earth shortage Despite strong orders, Q1 missed estimates with negative $291M free cash flow, Dark Eagle hypersonic faced delays, Ultra Maritime integration risk persists, and a rare-earth magnet shortage looms (U.S. produces 300 tons vs. 48,000 tons demanded, with a January 2027 China ban).

    These are real counterweights that could pressure the stock if execution and supply issues worsen.

▲2

Lockheed's record backlog and new missile deals cement multi-year growth

  • New supply-chain deals reduce rare-earth and component risks Lockheed signed an MOU with NioCorp for up to 15 tonnes of scandium oxide annually and another with GM Defense to improve supply chain and manufacturing. These moves help secure critical materials and components, easing production bottlenecks and supporting future growth.

    These are new agreements that address supply-chain vulnerabilities, a key risk for Lockheed.

  • Golden Dome and AI intercept tests advance future programs The Pentagon set funds and dates for the Golden Dome space missile defense program, with $3.2B for prototypes and potential tens of billions in future contracts. Lockheed also tested AI-driven intercepts, showing technological leadership. These support long-term growth prospects.

    These are new developments that position Lockheed for major future contracts and demonstrate innovation.

▲3▼1

Lockheed Wins Up to $58.6B Patriot Deal as Iran War Lifts Missile Demand

  • Up to $58.6B Patriot missile contract The U.S. Army awarded Lockheed a contract worth up to $58.6 billion to produce Patriot interceptor missiles, converting a one-year deal into a seven-year plan through 2032. This locks in long-term revenue and lets Lockheed triple PAC-3 MSE production by 2030, pushing the stock up.

    This is the single largest new contract this period and directly drives future revenue and production capacity.

  • Iran war boosts missile sales and guidance The ongoing war involving Iran drove Lockheed's missile sales up about 20% to $4.1 billion and helped push its order backlog to a record $230.4 billion. Lockheed raised full-year sales and profit guidance, and the stock jumped as much as 10% on the news.

    It explains the demand surge behind the stock move and confirms the war is a direct earnings driver.

  • Pentagon seeks $18.2B for missile replenishment The Pentagon's $67 billion emergency funding request includes $18.2 billion to replace advanced missiles like Patriot and THAAD, plus $100 million for Lockheed's classified Joint Advanced Tactical Missile. This signals more orders ahead, supporting the stock.

    It shows fresh government demand that will flow to Lockheed's missile programs.

  • Rare-earth magnet shortage threatens supply The U.S. produces only 300 tons of rare-earth magnets versus 48,000 tons of demand, and a January 2027 deadline will bar defense contractors from buying from China. Lockheed could face supply chain problems and higher costs, a real risk to production.

    It is the main counterweight this period, highlighting a supply risk that could hurt Lockheed's ability to deliver.

▲3

Lockheed Q2 Beat and Record Backlog Drive Stock Surge

  • Q2 earnings beat and raised guidance Lockheed reported Q2 sales of $20.1 billion (up 11%) and earnings of $7.94 per share, beating estimates. It raised full-year sales and profit guidance. The stock jumped over 10% as profits rebounded sharply and free cash flow turned positive $2.9 billion.

    This is the main new event that directly caused the stock's double-digit gain this period.

  • Record $230 billion backlog on $65 billion new orders Lockheed booked $65 billion in new orders, pushing its backlog to a record $230 billion, up 38% from a year ago. This includes a $35 billion THAAD contract. A large backlog gives years of revenue visibility and supports the stock.

    It shows strong demand and future revenue, a key reason investors are bullish.

  • New $10.5 billion Special Operations logistics contract Lockheed won a 12-year, $10.5 billion contract to provide worldwide logistics support for U.S. Special Operations Forces. This adds long-term services revenue and extends an existing relationship, boosting confidence in steady earnings.

    It is a new large contract award that adds to Lockheed's growth story.

  • New low-cost Patriot interceptor and counter-drone system; hypersonic delays Lockheed unveiled a new Patriot interceptor (ACE) that could cost less than half the current missile, and a new counter-drone system (MORFIUS X-Rotor). These could open new sales. However, its Dark Eagle hypersonic missile faces delivery delays due to manufacturing defects, a negative.

    These product developments show innovation but also highlight execution issues, balancing the positive earnings news.

▲3▼1

Lockheed's missile-defense production ramp and space wins drive new growth

  • Long-term framework agreements to triple/quadruple missile production Lockheed signed long-term framework agreements with the U.S. government to accelerate Patriot PAC-3, THAAD, and PrSM production, aiming for a threefold to fourfold increase. This locks in years of demand visibility and supports investment in factories and suppliers, pushing the stock up.

    This is the core new event that directly boosts future revenue and investor confidence.

  • New $1.1B Golden Dome satellite award Lockheed won a roughly $1.1 billion award for 18 missile-tracking satellites under the U.S. Golden Dome missile-defense initiative. This adds a new space-based revenue stream and shows Lockheed is a key player in a major new defense program, supporting the stock.

    This is a fresh contract win that expands Lockheed's space business and taps into a new multibillion-dollar initiative.

  • Expands venture capital fund with $100M for Europe Lockheed is putting at least $100 million from its $1 billion venture fund into U.K. and European startups, opening a London office. This signals strategic growth and strengthens its transatlantic defense ties, which could lead to new technologies and partnerships, supporting the stock.

    This is a new capital deployment that shows Lockheed is investing for future growth and deepening its European presence.

  • Q1 earnings miss and negative free cash flow weigh on sentiment Lockheed's Q1 revenue was flat at $18.02 billion and earnings missed estimates, with a $125 million F-16 charge and negative free cash flow of $291 million. This execution stumble, plus integration risks from the Ultra Maritime deal, is a real counterweight that could pressure the stock even as long-term orders grow.

    This is the main negative from the period that balances the positive contract news and explains why the stock isn't rising more.

▲4

NATO Summit Deals and Record U.S. Defense Budget Lift Lockheed

  • NATO Summit delivers $57B in new procurement deals At the Ankara summit, NATO allies announced over $57 billion in new defense procurement, including Lockheed's first European ATACMS missile facility with Rheinmetall and a Patriot missile sustainment hub. These deals lock in long-term revenue and expand Lockheed's presence in Europe's rearmament push.

    This is the period's biggest new catalyst, directly adding to Lockheed's order book and future sales.

  • U.S. defense budget surge to $1.5T in 2027 The U.S. plans to spend $1 trillion on defense in 2026 and has requested $1.5 trillion for 2027, the largest increase since WWII. Lockheed, with its massive F-35 program and $186B+ backlog, is a prime beneficiary of this spending wave.

    This is a new, powerful demand driver that underpins Lockheed's long-term growth outlook.

  • Turkey may rejoin F-35 program, boosting demand President Trump is expected to allow Turkey back into the F-35 fighter program, potentially adding new orders for Lockheed. This follows Turkey's earlier removal over a Russian missile system, and re-entry would expand the F-35 customer base.

    This is a new geopolitical development that could directly increase F-35 sales and production volume.

  • Lockheed and Rheinmetall to produce ATACMS in Europe Lockheed signed a deal with Rheinmetall to build the first European ATACMS missile production line in Germany, starting as early as next year. This positions Lockheed to capture European defense budgets replenishing stockpiles after sending weapons to Ukraine.

    This is a new joint venture that opens a new production hub and revenue stream in Europe.

▲3

Lockheed's record backlog and new missile-defense orders outweigh weak Q1 results

  • New $347.5M Army missile-defense contract Lockheed won a $347.5 million U.S. Army contract to develop and test improvements to prototype air and missile defense systems. This adds to its growing missile-defense order book and signals continued Pentagon demand, pushing the stock up.

    A fresh contract award that directly boosts future revenue.

  • Successful GRIZZLY launcher drone-intercept test Lockheed's JAGM missile fired from a GRIZZLY launcher intercepted a Group 3 drone in under 45 days from integration to live fire. This proves rapid, low-cost counter-drone capability, opening a new sales avenue and supporting the stock.

    Demonstrates technological edge that can drive future orders.

  • Nears $3.5B deal for Ultra Maritime Lockheed is the frontrunner to buy Ultra Maritime, a naval anti-submarine warfare unit, for about $3.5 billion. The deal would expand its undersea warfare business, aligning with Pentagon pressure to boost weapons production, and is seen as a growth driver.

    A major acquisition that expands Lockheed's capabilities and revenue base.

Q2 2026
▲3▼1

Lockheed's record backlog and big awards offset by peace-deal selloff

  • Record $194B backlog and dividend streak Lockheed reported a record $194B order backlog, equal to over 2.5 years of sales, and extended its dividend growth streak to 23 straight years, signaling steady long-term demand and shareholder returns.

    This is a core positive fundamental that supports the stock's long-term value.

  • Major contract wins across key programs Lockheed won a $2.8B F-35/CH-53K package, a $514M GPS contract, and a seven-year THAAD interceptor deal worth up to $35B, reinforcing its dominant position in defense markets.

    These awards directly boost future revenue visibility and investor confidence.

  • GM Defense partnership to ease supply bottlenecks A new partnership with GM Defense aims to alleviate supply chain bottlenecks and increase missile production output, addressing a key operational constraint.

    This initiative could improve execution and meet rising demand, a positive operational development.

  • Peace deal selloff and weak Q1 execution An interim US-Iran peace deal triggered a 4.2% one-day selloff on lower demand fears, while Q1 revenue missed estimates by 0.9% with soft guidance—the weakest among major defense peers—signaling execution concerns.

    This captures the main negative forces pressuring the stock during the period.

June 2026
▲3▼1

Lockheed's record backlog and big awards offset by peace-deal selloff

  • Record $194B backlog and dividend streak Lockheed reported a record $194B order backlog, equal to over 2.5 years of sales, and extended its dividend growth streak to 23 straight years, signaling steady long-term demand and shareholder returns.

    This is a core positive fundamental that supports the stock's long-term value.

  • Major contract wins across key programs Lockheed won a $2.8B F-35/CH-53K package, a $514M GPS contract, and a seven-year THAAD interceptor deal worth up to $35B, reinforcing its dominant position in defense markets.

    These awards directly boost future revenue visibility and investor confidence.

  • GM Defense partnership to ease supply bottlenecks A new partnership with GM Defense aims to alleviate supply chain bottlenecks and increase missile production output, addressing a key operational constraint.

    This initiative could improve execution and meet rising demand, a positive operational development.

  • Peace deal selloff and weak Q1 execution An interim US-Iran peace deal triggered a 4.2% one-day selloff on lower demand fears, while Q1 revenue missed estimates by 0.9% with soft guidance—the weakest among major defense peers—signaling execution concerns.

    This captures the main negative forces pressuring the stock during the period.

▲3▼1

Lockheed wins $35B THAAD deal, backlog hits record $194B

  • Lockheed wins up to $35 billion THAAD interceptor contract The U.S. awarded Lockheed a seven-year contract worth up to $35 billion to quadruple THAAD interceptor production. This is a huge, long-term order that locks in revenue for years and shows strong Pentagon demand for missile defense, pushing the stock up.

    This is the biggest new contract and directly boosts future revenue.

  • Record $194 billion backlog and 23-year dividend growth Lockheed ended 2025 with a record $194 billion backlog, covering over 2.5 years of sales, and has raised its dividend for 23 straight years. This steady, recession-resistant income appeals to investors and supports the stock price.

    New data on backlog and dividend reinforces long-term stability.

  • GM talks to supply munition components to Lockheed General Motors is in discussions to supply munition components to Lockheed, building on their June 16 partnership to use GM's commercial factories. This could help Lockheed make weapons faster and ease supply bottlenecks, supporting future revenue.

    New detail on GM-Lockheed collaboration shows potential production boost.

  • Iran peace progress and limited defense spending outlook Progress in U.S.-Iran peace talks and analyst expectations of limited defense spending increases reduce the outlook for future weapons demand. This weighs on defense stocks like Lockheed, though it mainly affects sentiment, not existing orders.

    This is the main new negative pressure on the stock this period.

▲2▼1

Lockheed's record backlog and production push outweigh peace-deal selloff

  • US-Iran interim peace deal sparks defense selloff An interim US-Iran peace deal raised hopes of less conflict, so investors sold defense stocks, including Lockheed, on fears of lower future weapons demand. The stock fell 4.2% in one day. This is a real headwind, but it mainly hits sentiment, not existing orders.

    This is the main new negative force behind LMT's recent price drop.

  • GM Defense partnership to expand weapons production Lockheed and GM Defense signed an agreement to use GM's commercial factories and parts know-how to make weapons faster. This helps Lockheed ramp up missile output as the Pentagon pushes for more munitions, supporting future revenue and easing supply bottlenecks.

    This new partnership directly addresses Lockheed's production capacity and supply chain, a key growth enabler.

  • New multi-billion-dollar contract awards Lockheed won a $2.8 billion Pentagon package for F-35 sustainment and CH-53K work, plus a $514 million GPS satellite contract and other missile awards. These add to its record backlog, giving long-term revenue visibility even as peace headlines swirl.

    These fresh contract wins show demand remains strong despite geopolitical noise.

  • Q1 revenue miss and soft guidance Lockheed's first-quarter revenue of $18.02 billion missed estimates by 0.9%, and full-year guidance also fell short, making it the weakest among major defense peers. This is a real counterweight: execution issues could pressure the stock even as the long-term backlog stays strong.

    It provides a fair balance by highlighting a genuine negative that offsets the positive backlog story.

© 2026 MarketIVWhy